What is the etiology of Periodic Limb Movement Disorder (PLMD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Periodic limb movement disorder (PLMD) is primarily caused by dysfunction in the central nervous system's dopaminergic pathways, and its etiology is multifactorial, involving medical conditions, medications, and lifestyle factors. The primary mechanism involves dysfunction in the central nervous system's dopaminergic pathways, particularly in the basal ganglia and spinal cord 1. Several medical conditions are associated with PLMD, including iron deficiency (especially low ferritin levels below 50 ng/mL), renal failure, diabetes, peripheral neuropathy, spinal cord injuries, and neurodegenerative disorders like Parkinson's disease. Certain medications can trigger or worsen PLMD, including antidepressants (particularly SSRIs and SNRIs), antipsychotics, lithium, and some antihistamines 1.

Key Factors Contributing to PLMD

  • Iron deficiency, particularly low ferritin levels below 50 ng/mL, is a significant contributor to PLMD, as evidenced by the American Academy of Sleep Medicine's suggestion to use ferrous sulfate in patients with appropriate iron status 1
  • Renal failure, diabetes, peripheral neuropathy, spinal cord injuries, and neurodegenerative disorders like Parkinson's disease are also associated with PLMD
  • Medications such as antidepressants, antipsychotics, lithium, and some antihistamines can trigger or worsen PLMD
  • Genetic factors likely play a role, as PLMD sometimes runs in families
  • Age is another factor, with prevalence increasing significantly in older adults

Relationship with Restless Legs Syndrome (RLS)

The condition frequently co-occurs with restless legs syndrome (RLS), suggesting shared pathophysiological mechanisms, though they are distinct disorders 1. Understanding these various contributing factors is essential for proper diagnosis and targeted treatment approaches. The diagnosis of PLMD is based on the frequency of periodic limb movements during sleep (PLMS) and the presence of clinically significant sleep disturbance and/or daytime dysfunction.

From the Research

Etiology of Periodic Limb Movement Disorder

The etiology of periodic limb movement disorder (PLMD) is complex and multifactorial. Several studies have investigated the underlying mechanisms and potential causes of PLMD.

  • Dopaminergic dysfunction is considered a key factor in the development of PLMD, particularly in patients with restless legs syndrome (RLS) 2, 3, 4.
  • Iron deficiency has also been proposed as a potential contributor to PLMD, with some studies suggesting that iron supplementation may be beneficial in reducing symptoms 5, 6.
  • Other potential underlying mechanisms include thalamic glutamatergic hyperactivity, cortical-subcortical interplay, and a pure motor mechanism originating in the spinal cord 5.
  • PLMD has also been associated with various medical and neurological disorders, including sleep apnea syndrome, narcolepsy, and REM sleep behavior disorder 2, 5.

Genetic and Pathophysiological Correlates

Research has identified several genetic and pathophysiological correlates of PLMD, including:

  • Separable PLM phenotypes, which may be associated with distinct underlying patho-mechanisms 5.
  • Nocturnal features, such as the ratio of limb movements and distribution throughout the night, which may vary across age and co-morbid clinical conditions 5.
  • Associations between PLM phenotypes and major neurologic and psychiatric disorders, although these remain controversial 5.

Clinical Significance and Treatment

PLMD can lead to significant sleep fragmentation and functional impairment, including hyperactivity and delayed language development in children, and poor concentration and work performance in adults 2, 5.

  • Longitudinal data demonstrate that individuals with PLMD are at greater risk of depression, anxiety, and dementia 5.
  • Treatment options for PLMD include dopaminergic agents, such as pramipexole, ropinirole, and rotigotine, as well as other medications like gabapentin enacarbil and pregabalin 3, 4, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.